The novel approach of this peptide represents a significant advance in the management of type 2 diabetes. Unlike existing therapies, tirzepatide impacts two pathways – GLP-1 and GIP – leading to improved glucose https://tirzepatidepeptide617402.designi1.com/62728029/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment